Delivery Order SPE2DB20D1109-SPE2DB23FN22V

Award Date 12/22/22
Potential Completion Date 12/23/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,087.04 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Tobramycin 300 mg/5 ml ampules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical products to support military healthcare programs globally. The contract has an ultimate completion date of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of Tobramycin 300 mg/5 ml ampules, a specialty pharmaceutical product, with a total potential value of $2,037.22. The contract has a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,790.98 firm fixed-price contract is for the delivery of Tobramycin 1.2 GM vials, a pharmaceutical product used to treat bacterial infections. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which allows the agency to efficiently procure a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,157.19, is for the provision of Tobramycin Pak 300 mg/5 ml, a pharmaceutical product. The delivery order has a firm fixed price structure and a completion date of January 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the prime...
This is a $1,023.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Tobramycin-Dexameth Ophth Susp 5ML, a pharmaceutical product, with a period of performance through May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,274.97 contract is for the delivery of 4,564,599,030 units of Gentamicin 800 mg/20 ml vials. This delivery order is part of a larger $999,999,999 IDC that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,728.47, is for the delivery of Tobrex 0.3% eye ointment, 3.5g. The award has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,831.31 firm fixed-price contract is for the supply of Piperacil-Tazobact 4.5 GM vials, a type of antibiotic medication. The contract has an ultimate completion date of May 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $3,485.97 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOBREX 0.3% eye ointment, 3.5 grams, with a performance period ending on May 9, 2024. The contract is a firm-fixed-price arrangement and was not set aside for any specific business size or type. Amerisourcebergen holds a larger $999,999,999...
This is a $16,489.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FN22V
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The order is for 4,559,444,890 units of TOBRAMYCIN 300 MG/5 ML AMPULE, a pharmaceutical product, at a firm fixed price of $1,092.35. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000.00. These IDCs enable the DLA and other federal agencies to efficiently procure essential pharmaceutical products and medical supplies to support military, veterans, and other government healthcare programs.

Generated 2/27/25, 10:35 AM